Bortezomib 68001-0534

Product NDC

68001-0534

Manufacturer: Bluepoint Laboratories
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: July 31, 2022
Listing Expires: December 31, 2026
Application: ANDA212958

Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bortezomib	3.5 mg/1

Drug Class

Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]

Packaging Options(1)

68001-0534-36

1 VIAL in 1 CARTON (68001-534-36) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

View →